Proteostatis's IPO Prices Well Below Expected Range, But Sells More Shares
February 11, 2016 at 07:37 AM EST
Proteostasis Therapeutics Inc. said Thursday its initial public offering of 6.25 million shares priced at $8 a share, well below the expected per-share range of $12 to $14.
